In March 2025, the company announced new strategies to get a immediate-to-buyer presenting of its Wegovy weight loss drug. The company established a different pharmacy, referred to as NovoCare, which would charge shoppers $499 a month for usage of the drug, under half the cost of the drug as a result of other pharmaceutical distribution networks.[5